Researchers from the International Working Group recommend categorizing biomarker-positive, cognitively normal individuals as ...

Jean Sachs, CEO of Living Beyond Breast Cancer explains what biomarker testing is and why it plays a crucial role in breast cancer treatment. Plus, Aliya Omer with AstraZeneca discusses recent ...

The ability to possibly detect Alzheimer’s disease before symptoms emerge using blood-based biomarkers has introduced new ...

However, it's reasonable to expect that many cognitively unimpaired people will soon have access to affordable Alzheimer's biomarker tests, the editorialists pointed out. The IWG group argued that ...

Blood biomarker tests for Alzheimer’s disease are increasingly making the jump from research to clinical practice, new ...

Blood biomarker tests are one diagnostic tool under developement. Roche recently presented data at the 17th Clinical Trials in Alzheimer’s Disease congress (CTAD) on two new Alzheimer’s ...

For blood alcohol testing, Phosphatidylethanol (PEth) testing is the gold standard. Unlike CDT, LFT and MCV blood tests, PEth is a direct biomarker of alcohol. This means that it is only present in ...

Four leading cancer research organizations in the United States and Canada announce the opening of patient enrollment to ...

The firm is nearing the launch of a liver disease test and working with the FDA to develop standards for the detection of ...

Today, the World Health Organization (WHO) published the preferred product characteristics (PPC) of blood-based biomarker ...

In an interview with Targeted Oncology, Jacob Stein, MD, MPH, discussed nab-sirolimus and its impact on patients with ...

Share on Pinterest Two experimental blood tests have shown promise in picking up on early signs of Alzheimer’s disease. Image credit: MaaHoo/Stocksy. One area is focusing on biomarkers ...